StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) shareholders

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.1%
0M of 13M shares
Institutional holders
5
3 new, 33 sold out
Net institutional buying
-3M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Highbridge Capital Management, LLC8,000,0009.90%13G (passive)Jun 30, 2025
683 Capital Partners, LP
Joint filing with 683 Capital Management, LLC (5.36%), Zweiman Ari (5.36%)
5,435,0005.36%13G (passive)Sep 22, 2025
Heights Capital Management, Inc.
Joint filing with CVI Investments, Inc. (5.90%)
4,000,0005.90%13G (passive)Jun 26, 2025
Tang Capital Management, LLC
Joint filing with Kevin Tang (7.80%), Tang Capital Partners, LP (7.29%)
3,910,3047.80%13G (passive) amendmentMar 31, 2025
Steven Boyd
Joint filing with Armistice Capital, LLC (9.99%)
3,357,9539.99%13G (passive) amendmentSep 30, 2024
Tang Capital Partners, LP
Joint filing with Tang Capital Management, LLC (9.99%), Kevin Tang (9.99%)
3,098,6159.99%13G (passive) amendmentDec 31, 2023
Millennium Group Management LLC
Joint filing with Integrated Core Strategies (US) LLC (8.20%), Millennium Management LLC (8.20%) and 1 more
1,072,6908.20%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RVPHValueChange% of portfolio
EMC Capital Management6,6960.05%$3.00KNew0.00%
TD Waterhouse Canada Inc.6250.00%$412–0.00%
Purpose Unlimited Inc.4050.00%$259–0.00%
Mosley Wealth Management10.00%$1New0.00%
Miller Global Investments, LLC10.00%$1New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202650M0.1%3 / 00 / 330M3M
Q1 2026353M22.3%14 / 74 / 223M0M
Q4 2025461M4.3%14 / 129 / 90M0M
Q3 2025410M3.6%7 / 1010 / 110M0M
Q2 2025461M5.5%11 / 99 / 130M0M
Q1 2025490M2.8%19 / 119 / 120M0M
Q4 2024420M3.0%18 / 108 / 90M0M
Q3 2024330M3.8%9 / 87 / 50M0M
Q2 2024310M2.6%9 / 124 / 50M0M
Q1 2024280M2.1%3 / 125 / 110M0M
Q4 2023360M2.0%16 / 143 / 30M0M
Q3 2023240M1.0%5 / 88 / 40M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

8 funds held RVPH in Q1 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of RVPHValue% of fundAs of
Fidelity Nasdaq Composite Index Fund9980.01%$4080.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Laxminarayan BhatPresident and CEO, Director2,484,24418.95%Mar 20, 2026
Narayan PrabhuChief Financial Officer100,0000.76%Mar 20, 2026
Parag SaxenaDirector4,046,00030.86%Dec 19, 2025
Leslie D. FuntleyderDirector––Dec 19, 2025
Purav PatelDirector75,6070.58%Dec 19, 2025
Richard A. MargolinDirector––Dec 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Purav Patel
Director
Nov 18, 2022Buy+3,000$4.69$14.07K43,547
Narayan Prabhu
Chief Financial Officer
Sep 30, 2022Buy+50,000$1.66$83.00K100,000
Narayan Prabhu
Chief Financial Officer
Jun 30, 2022Buy+50,000$1.21$60.50K50,000
Vedanta Associates-R, LP
10% owner
Jun 1, 2021Buy+399,000$3.75$1.50M399,000
Vedanta Associates-R, LP
10% owner
Jun 1, 2021Buy+931,000$3.75$3.49M931,000
Parag Saxena
Director, 10% owner
Dec 14, 2020Award+197,500––2,121,750
Glazer Capital, Llc
10% owner
Dec 8, 2020Sale−367,000$10.88$3.99M0
Sander Gerber
10% owner
Dec 8, 2020Other−710,000$10.88$7.72M0
Sander Gerber
10% owner
Dec 7, 2020Sale−50,000$11.51$575.50K710,000
Glazer Capital, Llc
10% owner
Dec 3, 2020Other−606,360$10.88$6.60M0
Paul J. Glazer
10% owner
Dec 2, 2020Sale−261$11.00$2.87K606,360
Glazer Capital, Llc
10% owner
Dec 1, 2020Sale−5,362$11.00$58.98K606,621
Glazer Capital, Llc
10% owner
Nov 27, 2020Sale−5,969$10.90$65.06K611,983
Paul J. Glazer
10% owner
Nov 24, 2020Sale−7,103$10.90$77.42K617,952
Paul J. Glazer
10% owner
Nov 23, 2020Sale−23,611$10.90$257.36K625,055
Paul J. Glazer
10% owner
Nov 18, 2020Sale−896$10.90$9.77K648,666
Paul J. Glazer
10% owner
Nov 17, 2020Sale−127$10.90$1.38K649,562
Paul J. Glazer
10% owner
Nov 16, 2020Sale−305$10.90$3.32K649,689
Glazer Capital, Llc
10% owner
Nov 11, 2020Sale−5$10.90$55649,994
Paul J. Glazer
10% owner
Nov 6, 2020Sale−1$10.90$11649,999
Paul J. Glazer
10% owner
Nov 3, 2020Sale−57,616$10.85$625.13K650,000
Paul J. Glazer
10% owner
Nov 2, 2020Sale−1$11.50$12707,616
Sander Gerber
10% owner
Nov 2, 2020Sale−50,000$10.87$543.50K760,000
Paul J. Glazer
10% owner
Sep 29, 2020Sale−2$11.50$23707,617
Paul J. Glazer
10% owner
Sep 17, 2020Sale−1,000$10.80$10.80K707,619
Paul J. Glazer
10% owner
Sep 14, 2020Sale−1$10.80$11708,619
Securities Usa Llc Mizuho
10% owner
May 8, 2020Sale−51,000$10.62$541.62K766,750
Sander Gerber
10% owner
Mar 20, 2020Buy+10,000$10.37$103.70K810,000
LLC Tenzing
10% owner
Aug 30, 2018Buy+33,000$10.00$330.00K1,924,250
Rahul Nayar
Chief Executive Officer, Director, 10% owner
Aug 30, 2018Buy+33,000$10.00$330.00K1,924,250
Parag Saxena
Chairman of the Board, Director, 10% owner
Aug 30, 2018Buy+33,000$10.00$330.00K1,924,250
Rahul Nayar
Chief Executive Officer, Director, 10% owner
Aug 23, 2018Buy+310,000$10.00$3.10M1,891,250
Parag Saxena
Chairman of the Board, Director, 10% owner
Aug 23, 2018Buy+310,000$10.00$3.10M1,891,250
LLC Tenzing
10% owner
Aug 23, 2018Buy+310,000$10.00$3.10M1,891,250

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
6.7
At 0M shares a day
Change since last report
+0.8%
From 0M shares
Short volume, 20 days
50.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Reviva Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 368 shares on Sep 2, 2026 over the last 90 days.

See a number that looks wrong?